Javier Torres-Jiménez, Ana Paisan, Mariano Ponz-Sarvise, Bruno Bockorny, Marta Gil-Martin, Ricardo Cubedo, Luis G. Paz-Ares, Ana Landa-Magdalena, Gerburg M. Wulf, Paula Sabat, Fabio Franco Perez, Myriam Fabre, Álvaro González, Patricia Gonzalez, Isabel Egaña, Susana Roman, Laureano Simon, Ignacio Garcia-Ribas, Ander Urruticoechea. "First-in-human phase 1 dose escalation trial of OMTX705, a novel anti-fibroblast activation protein (FAP) antibody drug conjugate (ADC), in monotherapy and in combination with pembrolizumab in patients with solid tumors.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.3028